Echo45 Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$491K Sell
409
-43
-10% -$43.9K 0.25% 45
2026
Q1
$416K Sell
452
-33
-7% -$33.5K 0.23% 47
2025
Q4
$521K Sell
485
-61
-11% -$58.3K 0.3% 46
2025
Q3
$417K Sell
546
-16
-3% -$11.9K 0.24% 38
2025
Q2
$438K Buy
562
+1
+0.2% +$777 0.28% 37
2025
Q1
$463K Sell
561
-63
-10% -$52.4K 0.31% 33
2024
Q4
$488K Buy
624
+103
+20% +$85.3K 0.32% 31
2024
Q3
$458K Sell
521
-48
-8% -$43.2K 0.3% 28
2024
Q2
$515K Sell
569
-82
-13% -$65.6K 0.36% 27
2024
Q1
$506K Sell
651
-7
-1% -$4.98K 0.36% 24
2023
Q4
$384K Buy
658
+24
+4% +$14K 0.3% 26
2023
Q3
$341K Sell
634
-57
-8% -$29.4K 0.29% 26
2023
Q2
$324K Sell
691
-62
-8% -$26K 0.27% 27
2023
Q1
$259K Sell
753
-58
-7% -$19.6K 0.21% 33
2022
Q4
$297K Buy
811
+67
+9% +$23.8K 0.27% 34
2022
Q3
$241K Sell
744
-9
-1% -$2.85K 0.24% 31
2022
Q2
$244K Sell
753
-41
-5% -$12.3K 0.23% 40
2022
Q1
$227K Sell
794
-122
-13% -$31.4K 0.18% 68
2021
Q4
$253K Buy
+916
New +$232K 0.2% 78

Other funds holding LLY

Echo45 Advisors's LLY Position: Q2 2026 in Review

Echo45 Advisors reduced its Eli Lilly (LLY) stake by 9.5% in Q2 2026, selling an estimated $43.9K and leaving 409 shares worth $491K. The position accounts for 0.25% of the portfolio, ranked #45.

Echo45 Advisors first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. The position peaked at $521K in Q4 2025. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Echo45 Advisors held 409 shares of Eli Lilly worth $491K as of Q2 2026.
  • Echo45 Advisors sold 43 Eli Lilly shares in Q2 2026, an estimated $43.9K.
  • Eli Lilly made up 0.25% of Echo45 Advisors's portfolio in Q2 2026, its #45 holding.
  • Echo45 Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
  • Echo45 Advisors's Eli Lilly position peaked at $521K in Q4 2025.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Echo45 Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.